ACE2 and COVID-19: The renin-angiotensin-aldosterone system (RAAS), one of the major blood pressure regulatory pathways, could be involved in the pathogenesis of COVID-19, since SARS-CoV-2 uses angiotensin-converting enzyme-2 (ACE2) as the binding receptor to enter the cell.